These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 10849569)

  • 1. Oral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of erectile dysfunction.
    Goldstein I
    Int J Impot Res; 2000 Mar; 12(S1):S75-S80. PubMed ID: 10849569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of erectile dysfunction.
    Goldstein I
    Int J Impot Res; 2000 Mar; 12 Suppl 1():S75-80. PubMed ID: 10845768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy for erectile dysfunction: a randomized, double blind, unblinded active-controlled, cross-over study of the pharmacodynamics and safety of combined oral formulations of apomorphine hydrochloride, phentolamine mesylate and papaverine hydrochloride in men with moderate to severe erectile dysfunction.
    Lammers PI; Rubio-Aurioles E; Castell R; Castaneda J; Ponce de Leon R; Hurley D; Lipezker M; Loehr LA; Lowrey F
    Int J Impot Res; 2002 Feb; 14(1):54-9; discussion 60. PubMed ID: 11896479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term safety and efficacy of oral phentolamine mesylate (Vasomax) in men with mild to moderate erectile dysfunction.
    Padma-Nathan H; Goldstein I; Klimberg I; Coogan C; Auerbach S; Lammers P;
    Int J Impot Res; 2002 Aug; 14(4):266-70. PubMed ID: 12152116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacy and safety of sildenafil citrate (Viagra) and oral phentolamine for the treatment of erectile dysfunction.
    Ugarte F; Hurtado-Coll A
    Int J Impot Res; 2002 Aug; 14 Suppl 2():S48-53. PubMed ID: 12161768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial.
    Montorsi F; Nathan HP; McCullough A; Brock GB; Broderick G; Ahuja S; Whitaker S; Hoover A; Novack D; Murphy A; Varanese L
    J Urol; 2004 Sep; 172(3):1036-41. PubMed ID: 15311032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasomax for the treatment of male erectile dysfunction.
    Goldstein I; Carson C; Rosen R; Islam A
    World J Urol; 2001 Feb; 19(1):51-6. PubMed ID: 11289571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction.
    Skoumal R; Chen J; Kula K; Breza J; Calomfirescu N; Basson BR; Kopernicky V
    Eur Urol; 2004 Sep; 46(3):362-9; discussion 369. PubMed ID: 15306109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intracavernous auto-injection therapy with papaverine phentolamine via an auto-injection pen for patients with an erectile dysfunction: similar results achieved in family practice and urology].
    de Boer BJ; Lycklama a Nijeholt AA; Kleinjans HA
    Ned Tijdschr Geneeskd; 2001 Apr; 145(16):783-7. PubMed ID: 11346917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral phentolamine as treatment for erectile dysfunction.
    Becker AJ; Stief CG; Machtens S; Schultheiss D; Hartmann U; Truss MC; Jonas U
    J Urol; 1998 Apr; 159(4):1214-6. PubMed ID: 9507837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.
    Eardley I; Gentile V; Austoni E; Hackett G; Lembo D; Wang C; Beardsworth A
    BJU Int; 2004 Oct; 94(6):871-7. PubMed ID: 15476525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erectile response with vardenafil in sildenafil nonresponders: a multicentre, double-blind, 12-week, flexible-dose, placebo-controlled erectile dysfunction clinical trial.
    Carson CC; Hatzichristou DG; Carrier S; Lording D; Lyngdorf P; Aliotta P; Auerbach S; Murdock M; Wilkins HJ; McBride TA; Colopy MW;
    BJU Int; 2004 Dec; 94(9):1301-9. PubMed ID: 15610110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sildenafil citrate for erectile dysfunction in men receiving multiple antihypertensive agents: a randomized controlled trial.
    Pickering TG; Shepherd AM; Puddey I; Glasser DB; Orazem J; Sherman N; Mancia G
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1135-42. PubMed ID: 15607620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vardenafil improved patient satisfaction with erectile hardness, orgasmic function and sexual experience in men with erectile dysfunction following nerve sparing radical prostatectomy.
    Nehra A; Grantmyre J; Nadel A; Thibonnier M; Brock G
    J Urol; 2005 Jun; 173(6):2067-71. PubMed ID: 15879836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and safety of oral sildenafil in Thai men with erectile dysfunction: a randomized, double-blind, placebo controlled, flexible-dose study.
    Kongkanand A; Ratana-Olarn K; Ruangdilokrat S; Tantiwong A;
    J Med Assoc Thai; 2003 Mar; 86(3):195-205. PubMed ID: 12757058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erection hardness: a unifying factor for defining response in the treatment of erectile dysfunction.
    Mulhall JP; Levine LA; Jünemann KP
    Urology; 2006 Sep; 68(3 Suppl):17-25. PubMed ID: 17011372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of tadalafil in United States and Puerto Rican men with erectile dysfunction.
    Seftel AD; Wilson SK; Knapp PM; Shin J; Wang WC; Ahuja S
    J Urol; 2004 Aug; 172(2):652-7. PubMed ID: 15247754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, safety, and treatment satisfaction of tadalafil versus placebo in patients with erectile dysfunction evaluated at tertiary-care academic centers.
    Carson C; Shabsigh R; Segal S; Murphy A; Fredlund P; Kuepfer C;
    Urology; 2005 Feb; 65(2):353-9. PubMed ID: 15708052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erectile response to vardenafil in men with a history of nonresponse to sildenafil: a time-from-dosing descriptive analysis.
    Hatzichristou DG; Aliotta P; Auerbach S; Barkin J; Lording D; Murdock M; Wilkins HJ; McBride TA; Colopy MW; Carson CC;
    Clin Ther; 2005 Sep; 27(9):1452-61. PubMed ID: 16291418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.
    Roehrborn CG; McVary KT; Elion-Mboussa A; Viktrup L
    J Urol; 2008 Oct; 180(4):1228-34. PubMed ID: 18722631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.